Serotonin 6 receptor gene and schizophrenia: Case-control study and meta-analysis

Human Psychopharmacology

Volumn 27, Issue 1, 2012, Pages 63-69

  Kishi, Taro ^a,b   Fukuo, Yasuhisa ^b   Okochi, Tomo ^b   Kawashima, Kunihiro ^b   Kitajima, Tsuyoshi ^b   Inada, Toshiya ^c   Ozaki, Norio ^d   Musso, Giovanna M ^a   Kane, John M ^a   Correll, Christoph U ^a   Iwata, Nakao ^b  

^a ZUCKER HILLSIDE HOSPITAL   (United States)

^b FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c SEIWA HOSPITAL   (Japan)

^d NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

meta analysis; schizophrenia; serotonin 6 receptor gene (HTR6)

Indexed keywords

SEROTONIN 6 RECEPTOR;

CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; MEDLINE; PRIORITY JOURNAL; RECEPTOR GENE; REVIEW; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW;

ADULT; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; JAPAN; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, SEROTONIN; SCHIZOPHRENIA;

EID: 84856336129     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.1266     Document Type: Review

References (43)

1. Barrett JC, Fry B, Maller J, Daly MJ,. 2005. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265. (Pubitemid 40202029)
2. Begg CB, Mazumdar M,. 1994. Operating characteristics of a rank correlation test for publication bias. Biometrics 50 (4): 1088-1101.
3. Braff DL,. 2010. Prepulse inhibition of the startle reflex: a window on the brain in schizophrenia. Curr Top Behav Neurosci 4: 349-371.
4. Bymaster FP, Falcone JF, Bauzon D, et al,. 2001. Potent antagonism of 5-HT(3) and 5-HT(6) receptors by olanzapine. Eur J Pharmacol 430: 341-349. (Pubitemid 33050060)
5. Chiu HJ, Wang YC, Liou JH, et al,. 2001. Serotonin 6 receptor polymorphism in schizophrenia: frequency, age at onset and cognitive function. Neuropsychobiology 43: 113-116.
6. Cichon S, Craddock N, Daly M, et al,. 2009. Genomewide association studies: history, rationale, and prospects for psychiatric disorders. Am J Psychiatry 166: 540-556.
7. Dawson LA, Nguyen HQ, Li P,. 2000. In vivo effects of the 5-HT(6) antagonist SB-271046 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5-HT, glutamate and aspartate. Br J Pharmacol 130: 23-26. (Pubitemid 30248421)
8. DerSimonian R, Laird N,. 1986. Meta-analysis in clinical trials. Control Clin Trials 7: 177-188. (Pubitemid 17189972)
9. Dudbridge F,. 2003. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 25: 115-121. (Pubitemid 37064867)
10. Egger M, Davey Smith G, Schneider M, Minder C,. 1997. Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (7109): 629-634.
11. Finn DP, Fone KC, Beckett SR, Baxter JA, Ansell L, Marsden CA, Chapman V,. 2007. The effects of pharmacological blockade of the 5-HT(6) receptor on formalin-evoked nociceptive behaviour, locomotor activity and hypothalamo-pituitary-adrenal axis activity in rats. Eur J Pharmacol 13 569 (1-2): 59-63.
12. Greenwood TA, Lazzeroni LC, Murray SS, et al,. 2011. Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the consortium on the genetics of schizophrenia. Am J Psychiatry 168: 930-946.
13. Holmans PA, Riley B, Pulver AE, et al,. 2009. Genomewide linkage scan of schizophrenia in a large multicenter pedigree sample using single nucleotide polymorphisms. Mol Psychiatry 14 (8): 786-795.
14. King MV, Sleight AJ, Woolley ML, Topham IA, Marsden CA, Fone KC,. 2004. 5-HT6 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing consolidation-an effect sensitive to NMDA receptor antagonism. Neuropharmacology 47: 195-204. (Pubitemid 38824643)
15. King MV, Marsden CA, Fone KC,. 2008. A role for the 5-HT(1A), 5-HT4 and 5-HT6 receptors in learning and memory. Trends Pharmacol Sci 29 (9): 482-492.
16. King MV, Spicer CH, Sleight AJ, Marsden CA, Fone KC,. 2009. Impact of regional 5-HT depletion on the cognitive enhancing effects of a typical 5-ht(6) receptor antagonist, Ro 04-6790, in the novel object discrimination task. Psychopharmacology (Berl) 202: 111-123.
17. Kirov G, Zaharieva I, Georgieva L, et al,. 2009. A genome-wide association study in 574 schizophrenia trios using DNA pooling. Mol Psychiatry 14: 796-803.
18. Kishi T, Kitajima T, Ikeda M, et al,. 2009. Association study of clock gene (CLOCK) and schizophrenia and mood disorders in the Japanese population. Eur Arch Psychiatry Clin Neurosci 259: 293-297.
19. Kishi T, Fukuo Y, Kitajima T, et al,. 2011a. SIRT1 gene, schizophrenia and bipolar disorder in the Japanese population: an association study. Genes Brain Behav 10: 257-263.
20. Kishi T, Fukuo Y, Okochi T, et al,. 2011b. Serotonin 6 receptor gene is associated with methamphetamine-induced psychosis in a Japanese population. Drug Alcohol Depend 113: 1-7.
21. Kohen R, Metcalf MA, Khan N, et al,. 1996. Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor. J Neurochem 66: 47-56. (Pubitemid 26010763)
22. Moskvina V, Craddock N, Holmans P, et al,. 2009. Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk. Mol Psychiatry 14: 252-260.
23. Neale BM, Sham PC,. 2004. The future of association studies: gene-based analysis and replication. Am J Hum Genet 75: 353-362. (Pubitemid 39095812)
24. Ng MY, Levinson DF, Faraone SV, et al,. 2009. Meta-analysis of 32 genome-wide linkage studies of schizophrenia. Mol Psychiatry. 14 (8): 774-785.
25. O'Donovan MC, Craddock N, Norton N, et al,. 2008. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet 40: 1053-1055.
26. Ohmori O, Shinkai T, Hori H, Nakamura J,. 2002. Genetic association analysis of 5-HT(6) receptor gene polymorphism (267C/T) with tardive dyskinesia. Psychiatry Res 110: 97-102. (Pubitemid 34607606)
27. Pouzet B, Didriksen M, Arnt J,. 2002. Effects of the 5-HT(6) receptor antagonist, SB-271046, in animal models for schizophrenia. Pharmacol Biochem Behav 71: 635-643. (Pubitemid 34219214)
28. Psychiatric GWAS Consortium Coordinating Committee, Cichon S, Craddock N, et al. 2009. Genomewide association studies: history, rationale, and prospects for psychiatric disorders. Am J Psychiatry 166 (5): 540-556.
29. Psychiatric GWAS Consortium Steering Committee. 2009. A framework for interpreting genome-wide association studies of psychiatric disorders. Mol Psychiatry 14: 10-17.
30. Purohit A, Herrick-Davis K, Teitler M,. 2003. Creation, expression, and characterization of a constitutively active mutant of the human serotonin 5-HT6 receptor. Synapse 47: 218-224. (Pubitemid 36056835)
31. Ripke S, Sanders AR, Kendler KS, et al,. 2011. Genome-wide association study identifies five new schizophrenia loci. Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium. Nat Genet 43 (10): 969-976.
32. Rogers DC, Hagan JJ,. 2001. 5-HT6 receptor antagonists enhance retention of a water maze task in the rat. Psychopharmacology (Berl) 158: 114-119. (Pubitemid 33020829)
33. Schanze D, Ekici AB, Gawlik M, Pfuhlmann B, Reis A, Stober G,. 2011. Evaluation of risk loci for schizophrenia derived from genome-wide association studies in a German population. Am J Med Genet B Neuropsychiatr Genet 156: 198-203.
34. Shifman S, Johannesson M, Bronstein M, et al,. 2008. Genome-wide association identifies a common variant in the reelin gene that increases the risk of schizophrenia only in women. PLoS Genet 4: e28.
35. Shinkai T, Ohmori O, Kojima H, Terao T, Suzuki T, Abe K,. 1999. Association study of the 5-HT6 receptor gene in schizophrenia. Am J Med Genet 88: 120-122. (Pubitemid 29156446)
36. Skol AD, Scott LJ, Abecasis GR, Boehnke M,. 2006. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 38: 209-213. (Pubitemid 43177235)
37. Stean TO, Hirst WD, Thomas DR, et al,. 2002. Pharmacological profile of SB-357134: a potent, selective, brain penetrant, and orally active 5-HT(6) receptor antagonist. Pharmacol Biochem Behav 71: 645-654. (Pubitemid 34219215)
38. Tsai SJ, Chiu HJ, Wang YC, Hong CJ,. 1999. Association study of serotonin-6 receptor variant (C267T) with schizophrenia and aggressive behavior. Neurosci Lett 271: 135-137.
39. Vogt IR, Shimron-Abarbanell D, Neidt H, et al,. 2000. Investigation of the human serotonin 6 [5-HT6] receptor gene in bipolar affective disorder and schizophrenia. Am J Med Genet 96: 217-221. (Pubitemid 30180865)
40. Williams HJ, Norton N, Dwyer S, et al,. 2011. Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder. Mol Psychiatry 16 (4): 429-441.
41. Woolley ML, Bentley JC, Sleight AJ, Marsden CA, Fone KC,. 2001. A role for 5-ht6 receptors in retention of spatial learning in the Morris water maze. Neuropharmacology 41: 210-219. (Pubitemid 32728092)
42. Zintzaras E, Lau J,. 2008. Trends in meta-analysis of genetic association studies. J Hum Genet 53: 1-9.
43. Zintzaras E, Raman G, Kitsios G, Lau J,. 2008. Angiotensin-converting enzyme insertion/deletion gene polymorphic variant as a marker of coronary artery disease: a meta-analysis. Arch Intern Med 168: 1077-1089. (Pubitemid 351749225)